Beyond The Printed Page

  1. Lawrence Blatt: Biopharma Entrepreneur And Professional Musician 6/15/2020

    Lawrence Blatt, Ph.D., cofounder and CEO of Aligos Therapeutics, his latest biopharma entrepreneurial venture, provides insight into the music industry, as he happens to also be a professional musician.

  2. A Biopharma CEO Not Focused On Stock Price 5/25/2020

    BioNTech’s founder and CEO, Ugur Sahin, M.D., Ph.D., subject of an upcoming feature in Life Science Leader, provides perspective on the company’s IPO and stock price as a metric.

  3. Disappointments In Alzheimer’s Therapeutic Development — A Conversation With John LaMattina 4/30/2020

    A question from a reader for Life Science Leader's popular monthly Ask The Board column, prompts a Q&A discussion with John LaMattina, Ph.D., on the retreat from neuroscience R&D.

  4. Pamela Contag — A Veteran Biopharma Entrepreneur Worth Getting To Know 4/20/2020

    Veteran biopharma entrepreneur Pamela Contag discusses beneficial attributes for startup CEOs, along with some advice for women executives.

  5. What Wasn’t Included In The Print Article About Arrowhead’s Adversity Odyssey? 3/23/2020

    Rob Wright shares enlightening anecdotes from interview of Chris Anzalone, Ph.D., CEO of Arrowhead Pharmaceuticals.

  6. Food For Free – An Example Of How Life Science Cares Approaches Engagement 2/17/2020

    Food For Free is an example for how Life Science Cares engages with its community of greater Boston.

  7. Gaurav Shah — A Rare Disease Biopharma CEO Shares A Rare Experience 2/6/2020

    Dr. Gaurav Shah, M.D., CEO of Rocket Pharmaceuticals, shares some of his rare experiences, such as what it is like to be nominated (as a musician) for a GRAMMY award, his company’s upcoming rare disease day, and more.

  8. An Interview with Robert Hariri, M.D., Ph.D., CEO and founder of Celularity 1/28/2020

    A video of Life Science Leader chief editor, Rob Wright, interviewing Robert (Bob) Hariri, M.D., Ph.D., CEO and founder of Celularity, at the 2019 CNS Summit.

  9. Why Top Researchers And Physicians Enter The World Of Biopharma R&D 1/13/2020

    David Chang, M.D., Ph.D., founder and CEO of Allogene Therapeutics, along with numerous other physicians have opted to become biopharmaceutical executives, but one doesn’t have to go to medical school to be driven to make a difference for patients.

  10. Genmab’s Commercial Engine Aspirations 12/16/2019

    Jan G. J. van de Winkel, Ph.D., cofounder and CEO of Genmab, discusses the company’s aspirations to eventually commercialize its own products.